These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 798194

  • 1. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
    Vessby B, Lithell H, Boberg J, Hellsing K, Werner I.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
    [Abstract] [Full Text] [Related]

  • 2. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA, Ylikahri R, Huttunen JK.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [Abstract] [Full Text] [Related]

  • 3. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG, Rössner S, Walldius G, Carlson LA.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H, Irsigler K.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract] [Full Text] [Related]

  • 5. The evaluation of lipoprotein changes during gemfibrozil treatment.
    Janus ED, Costa D, Ononogbu IC, Lewis B.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
    [Abstract] [Full Text] [Related]

  • 6. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
    Eisalo A, Manninen V.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
    [No Abstract] [Full Text] [Related]

  • 7. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A, Manninen V.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract] [Full Text] [Related]

  • 8. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
    Honorato J, Masso RM, Purroy A.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
    [No Abstract] [Full Text] [Related]

  • 9. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 10. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V.
    N Engl J Med; 1987 Nov 12; 317(20):1237-45. PubMed ID: 3313041
    [Abstract] [Full Text] [Related]

  • 11. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN, Ghosh P.
    Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [Abstract] [Full Text] [Related]

  • 12. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J, Salonen J, Kuuisto P, Virtamo J, Manninen V, Mälkönen M.
    Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [Abstract] [Full Text] [Related]

  • 13. Gemfibrozil in a group of diabetics.
    de Salcedo I, Gorringe AL, Silva JL, Santos JA.
    Proc R Soc Med; 1976 Nov 12; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
    [Abstract] [Full Text] [Related]

  • 14. Effect of gemfibrozil on serum lipid levels.
    Dahlén G, Gillnäs T, Børresen AL, Berg K, Ericson C.
    Artery; 1980 Nov 12; 7(3):224-31. PubMed ID: 7008748
    [Abstract] [Full Text] [Related]

  • 15. The effect of gemfibrozil on serum lipids in diabetic patients.
    Konttinen A, Kuisma I, Ralli R, Pohjola S, Ojala K.
    Ann Clin Res; 1979 Dec 12; 11(6):240-5. PubMed ID: 398183
    [Abstract] [Full Text] [Related]

  • 16. Summary of present data from a clinical trial of CI-719.
    Wilkening J, Schwandt P.
    Proc R Soc Med; 1976 Dec 12; 69 Suppl 2(Suppl 2):90-3. PubMed ID: 1019158
    [No Abstract] [Full Text] [Related]

  • 17. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A, Hamsten A, Silveira A, Fatah K, Goodall AH, Eriksson M, Angelin B, Hjemdahl P.
    Thromb Haemost; 1996 Aug 12; 76(2):171-6. PubMed ID: 8865525
    [Abstract] [Full Text] [Related]

  • 18. CI-719 in hyperlipoproteinaemia: interim data.
    Bremner WF, Third JL, Clark B, Corstorphine C, Lawrie TD.
    Proc R Soc Med; 1976 Aug 12; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Aug 12; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 20. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep 12; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.